Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

PTSD and Cancer

PTSD and Cancer

Posted by on Dec 11, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

“I think all too often we underestimate the impact of a cancer diagnosis on the mental health and well-being of the individual, thus it goes unaddressed.” ~Stephanie Zimmerman, MSN Receiving a diagnosis of cancer can bring on feelings of worry, fear, dread, anger, uncertainty and loss.  Research indicates that, for some people, these symptoms of...

Read More

Is changing treatment intensity after PET scan effective for patients with advanced stage Hodgkin lymphoma?

Posted by on Dec 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at changing treatment intensity after a PET scan for patients with advanced stage Hodgkin lymphoma. The authors concluded that reducing treatment intensity for patients with a negative PET scan can reduce negative side effects and improve long-term outcomes. Some background Advanced stage Hodgkin lymphoma (HL) can...

Read More

Is changing treatment intensity after PET scan effective for patients with advanced stage Hodgkin lymphoma?

Posted by on Dec 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at changing treatment intensity after a PET scan for patients with advanced stage Hodgkin lymphoma. The authors concluded that reducing treatment intensity for patients with a negative PET scan can reduce negative side effects and improve long-term outcomes. Some background Advanced stage Hodgkin lymphoma (HL) can...

Read More

Brentuximab vedotin as a first-line treatment for advanced Hodgkin’s lymphoma

Posted by on Dec 2, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate if a treatment combination including brentuximab vedotin (Adcetris) would be effective in treating patients with advanced Hodgkin’s lymphoma. This study concluded that treatment combinations with and without brentuximab vedotin were effective but one (BrECADD) was associated with fewer side...

Read More

The risk of developing a secondary cancer in patients treated for Hodgkin lymphoma

Posted by on Nov 27, 2017 in Hodgkin's lymphoma | 0 comments

  In a nutshell This review examined the risk of secondary cancer with different types of Hodgkin lymphoma treatment. The study concluded that combined modality treatment and more intense chemotherapy increase the risk of developing a secondary cancer, but also reduce the risk of early relapse. Some background Hodgkin lymphoma (HL) is widely...

Read More

Radiotherapy, chemo, and second cancers: what is the risk in Hodgkin lymphoma?

Posted by on Nov 17, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This review explored the risk of developing a secondary cancer after being treated for Hodgkin lymphoma with chemotherapy and/or radiotherapy. The review concluded that intensified chemotherapy and radiotherapy are more effective but are associated with a greater risk of developing a secondary cancer.  Some background Hodgkin...

Read More

Does Alcohol Increase Cancer Risk?

Does Alcohol Increase Cancer Risk?

Posted by on Nov 15, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

In July 2017, the American Society of Clinical Oncology (ASCO) conducted the National Cancer Opinion Survey to find out what people in the US know about cancer.  ASCO released the results in October.  The findings have already influenced recommendations made by the organization. Beliefs About Cancer Risk Among other questions, the survey asked  4,016...

Read More

Treatment options for elderly patients with early stage Hodgkin lymphoma

Posted by on Nov 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reviewed the treatments for elderly patients with early-stage Hodgkin lymphoma. The study concluded that combined chemotherapy and radiation therapy has the best outcomes, however the use of radiation therapy is not ideal. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, outcomes in...

Read More

Brentuximab vedotin plus dacarbazine or bendamustine to treat elderly patients with Hodgkin lymphoma

Posted by on Nov 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors compared the effectiveness of brentuximab vedotin (BV, Adcetris) plus dacarbazine versus BV plus bendamustine (Treanda). The authors concluded that both treatments are effective, but BV plus dacarbazine is recommended because it is safer than BV plus bendamustine.  Some background Hodgkin lymphoma (HL) is...

Read More

War on Cancer: The Right Metaphor?

War on Cancer: The Right Metaphor?

Posted by on Oct 22, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 6 comments

“For me, having lost my husband, it’s frustrating to hear publicly people saying to John McCain, ‘If anybody can beat this you can — you’re so tough.’  Not that it’s intentionally hurtful, but it does leave those of us who’ve lost a loved one thinking, ‘Was my loved one not tough enough? Did he not fight hard enough?'” ~Dannagal...

Read More

Using TARC blood levels to predict treatment success for patients with Hodgkin lymphoma

Posted by on Oct 17, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at how well thymus and activation-regulated chemokine (TARC) levels can predict outcomes for patients with Hodgkin lymphoma. The authors concluded that an early reduction in TARC levels can predict that treatment will be successful.  Some background Hodgkin lymphoma (HL) is generally considered a curable...

Read More